Defining and validating comorbidities and procedures in ICD-10 health data in ST-elevation myocardial infarction

Erik Youngson1, Robert C Welsh, Padma Kaul

  • 1University of Alberta, Edmonton Alberta Health Services Mazankowski Alberta Heart Institute University of Calgary, Calgary, Alberta, Canada.

Medicine
|August 12, 2016
PubMed

Insights

Administrative data accurately identifies ST-elevation myocardial infarction (STEMI) diagnoses and cardiac procedures. An algorithm using two prior visits effectively defines comorbidities for research without physician claims.

Area of Science:

  • Health Informatics
  • Cardiovascular Research
  • Data Validation

Background:

  • Administrative health databases are crucial for research, enabling the definition of diagnoses, procedures, and comorbid conditions.
  • Validating these administrative codes against comprehensive registries is essential for reliable research outcomes.
  • Physician claims databases are not universally available, necessitating alternative methods for data validation.

Purpose of the Study:

  • To validate administrative coding for ST-elevation myocardial infarction (STEMI) diagnosis and invasive cardiac procedures.
  • To determine an optimal algorithm for defining comorbidities using hospitalization and ambulatory data, excluding physician claims.
  • To assess the performance of International Classification of Diseases, 10th Revision (ICD-10) and Canadian Classification of Health Interventions (CCI) codes.

Main Methods:

  • A registry of STEMI patients served as the reference cohort, linked to administrative hospitalization and ambulatory databases.
  • Four administrative case definitions for STEMI diagnosis, procedures, and comorbidities were evaluated using ICD-10 and CCI codes.
  • Algorithm performance was assessed using metrics including the C statistic and Kappa statistic.

Main Results:

  • Administrative records correctly identified STEMI diagnoses in 94.0% of patients.
  • In-hospital cardiac procedures (coronary artery bypass grafting, percutaneous coronary intervention, angiogram) were accurately identified (Kappa 0.83-1.00).
  • An algorithm using two inpatient/ambulatory visits in the prior two years maximized positive predictive value (PPV) for comorbidities, ranging from 28.6% (heart failure) to 95.7% (myocardial infarction).

Conclusions:

  • International Classification of Diseases, 10th Revision (ICD-10) and Canadian Classification of Health Interventions (CCI) codes can reliably identify hospitalized STEMI patients and in-hospital cardiac procedures.
  • Comorbidities can be defined with high positive predictive value (PPV) using a definition of two inpatient/ambulatory visits within the previous two years.
  • This approach offers a validated method for using administrative data in cardiovascular research, even without access to physician claims.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
391
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
353